You are here

24-06-2019 | © picture 2 mins read

Honey bees – what’s in their guts?

Honey bees are an important species for ecology and economy, but their population has shrank worryingly. Prof. Philipp Engel focuses on gut microbiota, a critical factor for bee health, to understand how it evolved and diversified over time. His study addresses timely questions about evolution, ecology, microbiology and could eventually contribute to new strategies for managing bee colonies’ health.

22-05-2018 | © picture 6 mins read

Sailing the mysteries of old maps

Dr Joaquim Alves Gaspar is a man of the sea. After many years in the Portuguese Navy, he gave up plans to become an admiral in favour of pursuing a PhD in the History of Cartography. This second career led him to receive an ERC Starting Grant, the first awarded in this budding discipline. With his highly multidisciplinary team (he likes to say that, to work with him, one must be a mathematician fluent in Latin), and the experience obtained as a navigator and navigational instructor, Dr Gaspar hopes to understand how and when the first nautical charts were created. The MEDEA-CHART team is the best place in Portugal, and probably in the world, to study the history of nautical cartography, hoping that this work will provide the domain with its rightful recognition within world history.

16-11-2017 | Portrait: ©EPFL,Hillary Sanctuary - Research picture: ©EPFL,Alain Herzog 2 mins read

Could personalised neuroprosthetics make paralysed patients walk again?

Prof. Gregoire Courtine believes paralysed patients will be able to walk again. This belief has represented the focus of years of work aimed at regenerating the functions of the spinal cord after injury. Thanks to his ERC funding in both 2010 and 2015, Prof. Courtine and his team have been able to develop so-called “personalised neuroprosthetics” that have led immobile rats, and more recently monkeys, to overcome their paralysis.

11-05-2017 | Portrait and illustration: Photo Evolutionary Biology group (Isabel Gordo) | llustration: Macrophages with Escherichia coli 3 mins read

New knowledge to fight back against antibiotic resistance

The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.

01-04-2017 | © picture

Frontier science and business that makes a difference

Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

29-06-2016 | © picture 2 mins read

Stem cells: from frontier research project to promising spin-off company

Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.

30-10-2015 | image © Istockphoto 2 mins read

Animals "peer-pressured" into reacting to danger

ERC grantee Marta Moita and her team use cutting-edge experimental procedures to investigate how rats and flies learn to appropriately respond to danger from other individuals. The results of her study may teach us a lot about our own brains, and shed light on diseases that impair social behaviour.

10-02-2014 | Image: Lake Tanganyika  (© Adrian Indermaur) 4 mins read

If Darwin could have scuba dived...

If Darwin could have scuba dived, he would have enjoyed the East African lakes: Victoria, Malawi and Tanganyika. Here live the cichlids – a colourful fish which has evolved rapidly into thousands of species, emulating and surpassing Darwin's finches in the Galapagos. Prof. Walter Salzburger, an Austrian researcher, is using his ERC grants to study the diversity of cichlids from ecological, morphological and genetic viewpoints. He believes these unique fish provide an ideal model system to understand the "how" and the "why" in questions of evolutionary biology: questions that relate to all life on earth.

26-04-2012 | Pedro Medeiros © Boaventura de Sousa Santos 2 mins read

A new vision of Europe

Pursuing a sustainable development and broadening social justice and cohesion are some of the challenges that Europe is currently facing. What if we could learn how to solve these challenges by using the social and political innovations taking place in different corners of the globe? Professor Boaventura de Sousa Santos suggests that a new approach can be developed in Europe based on the diversity of practices elsewhere.

21-03-2012 | © Friedrich Miescher Institute for Biomedical Research 3 mins read

Investigating signaling molecules in breast cancer

Significant progress has been made in understanding breast tumour biology. However statistics indicate that the number of breast cancer patients and victims will continue to increase. Dr. Bentires-Alj, ERC Starting Grantee at the Friedrich Miescher Institute for Biomedical Research in Basel, and his team are studying the roles of the still under-explored family of protein-tyrosine phosphatases (PTPs) in both normal breast development and cancers. In a recent study, published in Nature Medicine in March 2012, Dr Bentires-Alj's team have revealed the fundamental role of the protein phosphatase SHP2 in breast cancer proliferation, invasion and metastasis.